Clinical cases 2.1 Material and methods
We present our experience with thoracic aortic emergencies. From May 2003 to September 2010, more than 200 patients were evaluated in our hospital for various emergencies affecting the entire aorta. Many patients required laparotomy or thoracotomy due to hemodynamic instability. From January 2000 to September 2010, we treated 80 patients using endovascular stent grafting, both in elective and in emergency repair. Endovascular procedures were performed in 25 patients for emergency lesions between May 2003 and September 2010. In this section, we describe the cases, procedures, and outcome. At our institution, we divide aortic emergencies into 5 groups:  Acute aortic syndrome: aortic dissection (5), penetrating aortic ulcer (2), intramural hematoma (2)  Ruptured thoracic aneurysm (5)  Symptomatic thoracic aortic pseudoaneurysm (3)  Traumatic (blunt) aortic disruption (4)  Aortobronchial fistula (1), aortoesophageal fistula (2)  Subclavian symptomatic pseudoaneurysm (1) The indications for treatment were aortic rupture in 5 patients (20%), persistent or recurrent pain in 8 patients (32%), hypotension or shock in 9 patients (36%), hemoptysis in 2 patients (8%), and acute renal failure in 1 patient (4%). Baseline characteristics and cardiovascular risk factors of our patients are given in Table 1 The mean diameter of the thoracic aorta in patients with ruptured thoracic aortic aneurysms was 79 ± 18 mm (range, 70-92 mm) . Mean diameter including all patients with thoracic aortic aneurysms and pseudoaneurysms (11 patients) was 77 mm (range, 40-110 mm) . The median interval between onset of symptoms and the endovascular procedure was 0.7 days (range, 0-6). We used four commercially available thoracic stent-graft prostheses: Talent ® (n=12, 48%), Valiant ® , (Medtronic Vascular, Santa Rosa, California, USA) (n=6, 24%), Relay ® (Bolton Medical, Florida, USA) (n=6, 24%), and AneuRx ® (Medtronic AVE, Cupertino, California, USA) (n=1, 4%). Each endoprosthesis consisted of a self-expanding nitinol stent, covered externally by a Dacron graft. The type of stent graft was selected depending on availability and surgeon preference. Data were collected on case report forms and checked for inconsistencies by two of the authors (R.L, P. JL).
Preprocedural diagnosis
Sizing of the endoprosthesis was based on centerline diameter measurements from contrast enhanced computed tomography (CT) angiography and three-dimensional image reconstructions; 10-20% oversizing was applied when selecting the stent graft diameter. Trans-esophageal echocardiography was used in all cases of acute aortic syndrome (Stanford type B acute aortic dissection, intramural hematoma, penetrating aortic ulcer) and in the patient with an aortobronchial fistula. Intravascular ultrasound was used in 3 of the patients with aortic dissection and for deployment of the stent graft in the patient with aortobronchial fistula.
Procedures
All surgical procedures were performed under general anesthesia in an operating room with angiographic and fluoroscopic equipment. Each patient received a single dose of antibiotic therapy (cefazolin) and 5000 units of heparin (except in ruptured aneurysms or head injuries). Cerebrospinal fluid (CSF) was drained in 8 hemodynamically stable patients (n=8). CSF pressure was monitored and maintained at 10 mmHg. CSF drainage was continued for 48 hours after surgery unless complications occurred. Hypotension was induced before device deployment when patients were stable. Intravascular access was by transfemoral insertion in one groin. An ultrastiff 0.035-inch Amplatz SuperStiff™ guidewire (Boston Scientific, Miami, Florida, USA) or Lunderquist ExtraStiff wire (Cook, Inc., Bloomington, Illinois, USA) was directed into the ascending aorta via a transverse arteriotomy. Using a percutaneous contralateral approach, a soft Terumo guidewire (Terumo Medical, Somerset, New Jersey, USA) and 6-F pigtail catheter (Cordis, Johnson and Johnson, Warren, New Jersey, USA) were directed into the ascending aorta. Intraoperative angiogram was then performed in a left anterior oblique view at 40º-60º. The stent graft delivery system was inserted through the access artery. After marking the left subclavian artery, the endoprosthesis was delivered and deployed. During deployment, systolic blood pressure was usually maintained below 80 mmHg.
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Cases 2.4.1 Cases 1-9. Acute aortic syndrome (9)
Five patients were treated during this period for symptomatic type B aortic dissection, 2 for symptomatic penetrating aortic ulcer and 2 for intramural hematoma. Median age was 60 years (range, 33-74 years). Seven patients were treated for persistent pain. One patient was treated for uncontrolled hypertension. One patient was treated for onset of acute renal failure (due to the dissection) and persistent pain. One patient was a 33-year-old male with Marfan syndrome who was treated for a symptomatic huge growth of a distal thoracic aorta dissection (10 cm in diameter) with a postdissection thoracoabdominal aneurysm ( Figure 1) . He presented at the emergency department with interscapular pain. The patient underwent a hybrid surgical procedure in a 2-stage intervention involving placement of a thoracic endoprosthesis (34 x 34 x 200 mm Valiant-Medtronic ® ) followed 2 days later by open repair of his visceral aorta using an aorto-aortic bypass Dacron graft with reimplantation of the 4 visceral vessels. He was discharged 32 days after the second procedure.
Another patient was a 60-year-old male who presented with acute-onset intense thoracic interscapular pain and hypertension. CT scan revealed an intramural hematoma complicated with penetrating aortic ulcers ( Figure 2 ). A 46 x 42 x 110-mm Talent ® stent-graft was deployed. Four days later, CT scan revealed a type I proximal endoleak. A proximal stent graft (46 x 46 x 130-mm Talent) was successfully delivered and deployed. The patient was discharged 6 days later. 
Cases 10-17. Ruptured thoracic aneurysms and symptomatic pseudoaneurysms (8)
Five patients were treated during this period for ruptured thoracic aneurysms and 3 patients for symptomatic thoracic pseudoaneurysms. Median age (all 8 patients) was 65 years (range, 44-80 years). Mean thoracic aorta diameter in patients with ruptured thoracic aortic aneurysms was 79 mm (range, 70-92 mm) ( Figure 3 ). On admission, 7 patients were hemodynamically unstable. One patient presented with hemoptysis. As an unusual presentation, we describe the case of a 46-year-old HIV-infected woman (stage B2) coinfected with hepatitis C virus and tuberculosis. She presented with persistent hemoptysis (ongoing for 3 days), interscapular pain, and fever. CT scan revealed a 40-mm upper thoracic pseudoaneurysm in close contact with the left bronchus ( Figure 4 ). The patient became hemodynamically unstable and went into cardiopulmonary arrest. After cardiopulmonary resuscitation and stabilization in the intensive care unit, she underwent successful exclusion of the lesion with a 26 x 26 x 155-mm Relay ® endoprosthesis placed distal to the origin of the left common carotid artery and covering the ostium of the left subclavian artery. The postoperative period was uneventful and she was discharged 11 days after surgery. Follow up was scheduled at 1, 3, 6, and 12 months. Her latest CT scan (36 months) showed patency of the endoprosthesis with no endoleaks. Her latest physical examination revealed no vascular abnormalities. Mortality in this group was very high (3 of 8 patients). Three of the 5 patients who died during their stay were in this group. 
Cases 18-21. Traumatic (blunt) aortic disruption (4)
In this group, all the patients were young (median age, 40 years [range, 26-58 years]) and were treated for hypotension or shock.
In all cases, the lesion was located at the aortic isthmus. A 26-year-old woman was admitted after a fall from 15 meters. CT scan revealed a blunt aortic disruption at the level of the proximal thoracic aorta (aortic isthmus), slightly distal to the left subclavian artery. The patient was unstable and therefore immediately transferred to the operating room. She underwent successful endovascular stent grafting (22 x 22 x 150 mm Relay ® endoprosthesis) of the ruptured thoracic aorta. The patient had multiple fractures, as well as hemothorax and liver contusion. She was discharged 54 days after surgery.
Cases 22-24: Aortobronchial fistula (1) and aortoesophageal fistula (2)
The patient with the aortobronchial fistula presented with massive (>400 cc) hemoptysis and hypotension. The other 2 patients were evaluated for hematemesis, malaise, and sudden hypotension. A 55-year-old male was referred to our hospital for evaluation of massive hemoptysis. CT with intravenous contrast revealed a ruptured para-anastomotic pseudo-aneurysm in the descending thoracic aorta. Intra-operative angiography confirmed the presence of an aortobronchial fistula at the site of the pseudo-aneurysm ( Figure 5 ). A 74-year-old man was referred to our hospital for evaluation of massive hematemesis and hypotension. Preoperative assessment was with blood samples and chest X-ray. A CT scan revealed a descending thoracic aneurysm measuring 100 mm in diameter. This aneurysm was displacing the esophagus (Figures 6 and 7) . In the emergency department, the patient became hemodynamically unstable and was transferred to the operating room. He underwent successful endovascular stent grafting (36 x 36 x 200 and 36 x 36 x 145-mm Relay ® endoprostheses). The patient died of a massive myocardial infarction on the third day after surgery. 
Case 25: Subclavian symptomatic pseudoaneurysm (1)
A 70-year-old Chinese man with a significant history of hypertension and smoking was referred to our hospital for evaluation of intermittent hemoptysis. On admission, he presented hemoptysis (>300 cc) and dyspnea. CT scan revealed a pseudoaneurysm measuring 30 mm x 20 mm at the origin of the left subclavian artery and in contact with the left pulmonary apex (Figure 8 ). The patient experienced 2 new episodes of massive hemoptysis with progressive anemia and was transferred immediately to the operating room. A Relay® covered selfexpandable thoracic endoprosthesis (36 mm x 36 mm x 145-mm) was successfully placed distal to the origin of the left common carotid artery and covering the left subclavian artery. A 16mm Amplatzer® vascular plug (AGA Medical Corporation, Plymouth, Minnesota, USA) was inserted through the left brachial artery to occlude the left subclavian artery without covering the left vertebral artery. Serology and culture studies were negative. The patient was discharged 13 days after the endovascular procedure. Follow-up was scheduled at 1, 6, and 12 months, and yearly thereafter. His latest examination revealed the recovery of left brachial and distal pulses. 
Results
A total of 41 endografts were implanted. Median diameter and length were 36 mm (range, 22-46 mm) and 135 mm (range, 100-200 mm), respectively. The characteristics of the endografts and types of lesion are described in Table 3. Lesions were excluded by 1 stent graft in 15 patients (60%, table 2), by 2 stent grafts in 4 patients (16%), and 3 stent grafts in 6 patients (24%). The stent grafts were all deployed at the intended position, which was predominantly in the distal aortic arch or proximal descending aorta, necessitating complete coverage of the ostium of the left subclavian artery in 6 of 25 patients (24%).
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LSA: Left subclavian artery. Technical success, defined as correct stent placement and accurate coverage of the affected site, was achieved in all 25 patients (100%). One patient required a proximal extension for a proximal type I endoleak 4 days after the procedure. One patient with a traumatic (blunt) aortic disruption required a proximal extension 20 days after the endovascular procedure for a proximal type I endoleak. Intraoperative mortality was 4% (1 patient who was in severe shock before surgery and died during stent graft implantation from a ruptured thoracic aneurysm). There was no conversion to open thoracotomy and no incidence of paraplegia after surgery. Median length of hospital stay was 18 days (range, 6-60 days).
Mortality
Overall hospital and 30-day mortality was 20% (n = 5). One patient (4%) died during surgery. Two patients died during their hospital stay due to multiorgan failure (after 17 and 80 days, respectively). One patient died of cardiorespiratory failure (postoperative day 15). One patient (treated for an aortoesophageal fistula) died on the third day after surgery of a massive myocardial infarction.
Follow-up
Follow-up was scheduled at 1, 6, and 12 months and yearly thereafter. Patients with endoleaks (type II) were followed closely at 3 to 6 months. Mean follow-up was 51 months (range, 4-96 months). Nineteen patients were followed up, 1 was lost to follow-up, and 5 died in hospital. Two patients (8%) died after discharge from hospital. One patient died of a cerebral hemorrhage after 8 months, the other died of an aortoesophageal fistula 4 months after discharge. Overall survival at 1 year was 72%. At the time of writing, 17 patients are still alive, with no evidence of new leaks, device migration, or other complications. One patient treated for an acute type B dissection required a proximal stent graft extension for a type I endoleak after 12 months. One patient (previously treated for an acute type B dissection) required a left renal angioplasty and stent for renal stenosis and hypertension after 13 months. One patient (treated for an intramural hematoma) required a distal stent graft after 48 months to repair postdissection sac growth. Although we had to cover the ostium of the left subclavian artery in 6 of 25 patients (24%), it was not necessary to revascularize the left subclavian artery, as no arm ischemia or vertebrobasilar ischemia was detected. According to the definitions of Chaikof et al. (Chaikof et al, 2002) , primary technical success was 80%. Table 4 shows results in terms of mortality and follow up.
Discussion
Vascular lesions and injuries to the thoracic aorta are associated with very high morbidity and mortality. Many patients with severe injuries die at the scene of the accident before being diagnosed or are severely ill on arrival at the emergency department. Table 4 . Intra-postoperative mortality and follow up.
Endovascular repair of a ruptured thoracic aorta was initiated in the mid-nineties. Dake et al. presented one of the first series of endovascular stent grafts for the treatment of descending thoracic aortic aneurysms in 1994 (Dake et al., 1994) . Since then, several authors have reported successful endovascular treatment of both chronic and acute lesions of the thoracic aorta (Dake, 2001; Kato et al., 1997; Fujikawa et al., 2001; Lachat et al., 2002; Czermak et al., 2002; Amabile et al., 2004; Dunham et al., 2004; Hoornweg et al., 2006; Alsac et al., 2008; Kaya et al., 2009) . Despite advances in surgical techniques, surgery for acute thoracic aortic rupture is associated with high morbidity and mortality rates (Doss et al., 2003; Dake et al., 1994) .
Open thoracic aortic repair carries the risk of severe complications affecting the heart, lungs, kidneys, and nervous system (spinal cord ischemia), with frequencies as high as 50%
Diagnosis and Treatment of Abdominal and Thoracic Aortic Aneurysms Including the Ascending Aorta and the Aortic Arch 154 (Lachat et al., 2002) . Mortality rates for elective open surgical repair of descending thoracic aortic aneurysm have been reported at 3-12%. Most reports, however, are from high-volume centers of excellence and national referral centers; therefore, the results may not reflect the actual experience worldwide (Schermerhorn et al., 2008) . Ruptured descending thoracic aortic aneurysm (rDTAA) is a cardiovascular catastrophe, associated with high morbidity and mortality. The vast majority of patients who suffer from rDTAA die before they reach hospital (Johansson et al., 1995) . rDTAA is less common than aortic dissection and traumatic aortic rupture, and the treatment of choice in most centers is thoracic endovascular aortic repair (TEVAR) . Open surgical repair of rDTAA presents very high mortality rates and is only feasible in referral centers. Mortality rates for open surgery vary from 30% to 60% depending on the series (Jonker et al., 2011) . Patients with rDTAA treated with TEVAR present lower mortality rates, although morbidity is also high. Recent reports present 30-day mortality rates of 15%-20%. Only highly specialized centers have reported mortality rates of between 25% and 30% after open repair of rDTAA (Jonker et al., 2010; Estrera et al., 2001) . A recent comparative study by Patel and colleagues showed a 30-day mortality of 11.4% after TEVAR compared with 26.5% after open repair of ruptured thoracic aortic dissections and aneurysms (Patel et al., 2009) . In endovascular repair of descending thoracic aortic aneurysms, the incidence rates of paraplegia and stroke usually range from 1% to 6% and from 2.5% to 5%, respectively. The risk of neurological complications may increase after endovascular repair of rDTAA, although it is still lower than that of open repair. The incidence of paraplegia and stroke after conventional surgical treatment of rDTAA may be as high as 12.5% and 25% (Jonker et al., 2011; Barbato et al., 2007) , providing even greater support for endovascular treatment of rDTAA. Although TEVAR is currently the most appropriate approach for the management of this often-fatal lesion, endovascular repair of rDTAA is still associated with considerable rates of neurological complications and procedure-related complications such as endoleak. In our series, mortality for thoracic endovascular aortic repair in the ruptured thoracic aneurysm group was high (2 patients out of 5: 40%). Previous medical comorbidities and severe preoperative shock were determinant factors. The prevalence of intramural hematoma in patients with acute aortic syndrome is 10%-20%, and approximately 10% of patients with symptomatic intramural hematoma develop aortic rupture. The signs of disease progression include aortic diameter ≥40 mm and thickening of the aortic wall ≥10mm. Close surveillance in these patients is critical (Geisbüsch et al., 2008) . The prevalence of penetrating aortic ulcer among patients presenting with acute aortic syndrome is about 2%-8%. Although frequently causing the same symptoms, penetrating aortic ulcer and classic aortic dissection must be distinguished, as they differ in their natural course. The rupture rate in symptomatic penetrating aortic ulcer is reported to be as high as 40% compared to 4% in Stanford type B dissection. Therefore, urgent repair is required in symptomatic cases (Geisbüsch et al., 2008; Tittle et al., 2002; Coady et al., 1996; Ganaha et al., 2002) . Signs of progression of this condition include aortic ulcer diameter >20 mm and ulcer depth >10 mm. Close surveillance is essential. Early mortality after TEVAR in penetrating aortic ulcer is reported at 0%-11%. Mediumterm outcomes have been published, with 1-, 3-, and 5-year survival rates of 85%, 75%, and 60%, respectively (Geisbüsch et al., 2008; Botta et al., 2008; Demers et al., 2004) .
In 2007, Estrera et al. published their series of 159 patients treated for acute type B aortic dissection. They concluded that mortality associated with complicated dissection was 17%. In contrast, 53% of patients with uncomplicated dissection were managed medically, with a mortality rate of only 1.2% (Estrera et al., 2007) . TEVAR should now be considered the gold standard for complicated acute type B thoracic dissections and symptomatic penetrating ulcers. In our series, the acute aortic syndrome group was quite homogeneous as regards age, initial presentation, postoperative period, and outcome. There was no in-hospital mortality, with 90% of patients alive during a mean follow-up of 62 months (range, 8-84 months). Traumatic aortic injury is the second commonest cause of death in patients after blunt injury; autopsy reveals that 15%-30% of deaths from blunt trauma involve aortic transection (Thompson & Morgan., 2009; Shorr, 1987) . Traumatic thoracic aortic rupture is a potentially lethal injury and leads to immediate death in 75%-90% of cases. Only about 10%-20% of victims reach the hospital alive. The most common site of aortic injury is the isthmus, where the relatively mobile thoracic aorta joins the fixed arch. Aortic rupture occurs at this site in 80% of pathological series and in 90% of the clinical series Thompson & Morgan., 2009) . Despite advances in surgical techniques, in emergency settings, open surgical repair of aortic rupture is still associated with a mortality rate of 18%-67% (Steingruber et al., 2007 , Karmy-Jones et al. 2003 Richens et al., 2002; Williams et al., 1994) . Most series report the technical success of TEVAR to be 81.1-100%, with a paraplegia rate of 0%. These series present low mortality and morbidity rates, with accompanying injuries as primary causes of morbidity and mortality (Urgnani et al., 2009 , Neuhauser et al., 2004 Rousseau et al., 2005) . Our results revealed considerable age differences between the traumatic (blunt) aortic rupture group and the other groups. This is due to the type of injury, which commonly occurs in young patients after high velocity trauma such as car accidents or falls from great heights. These patients commonly present multiple extremity and other fractures, vertebral or spinal cord injuries, and lung and visceral contusions, thus increasing the already high postoperative mortality. In spite of the many benefits in the short and medium terms, the long-term results of endovascular repair of traumatic aortic rupture remain a major issue in these relatively young patients. In the future, we expect to see the development and use of stent grafts specifically designed to treat aortic trauma. We present our experience with endovascular repair of thoracic aortic emergencies. Some of the cases we report are very unusual and therefore challenging, in terms of both diagnosis and treatment. In several cases the presenting symptom was hemoptysis. In patients with massive hemoptysis, lesions in the intrathoracic large vessels, including the supra-aortic arteries, must be considered in the differential diagnosis. Moreover, in patients with previous aortic surgery and hemoptysis, the physician must have a high index of suspicion (Kopp et al., 2009) . Aortobronchial fistula and aortoesophageal fistula can be difficult to diagnose and extremely complex to treat. These conditions are often devastating, and the results of surgery are usually very poor. Endovascular repair provides an alternative to very complex open surgical repair. Very few series in the literature analyze endovascular repair of these complex lesions, and data are mostly from case reports or small series.
Open surgery entails high morbidity and mortality, and mortality rates range from 25% to 60% (Thompson et al., 2002; Piciche et al., 2003; Liu et al., 2004) . As regards endovascular repair of aortobronchial fistula, a review of the literature revealed less than 60 cases treated using endovascular repair. These were all from small series (Wheatley et al., 2007; Pirrelli et al., 2006; Ribé et al., 2010) . Initial results are encouraging, with 30-day mortality rates below 10%; however, larger series with longer-term follow-up are still required (Pirrelli et al., 2006) . Both our results and those published in the literature indicate that endovascular repair of thoracic aortic emergencies is a promising approach. In some acute conditions, such as complicated type B thoracic dissections or ruptured thoracic aortic aneurysms, endovascular repair must be considered the treatment of choice. Larger series and longer follow-up are required for future assessment of these conditions.
Conclusion
Endovascular therapy may now be considered the first-line treatment for thoracic aortic emergencies, especially for ruptured thoracic aortic aneurysms and acute complicated dissections. Endovascular procedures reduce morbidity and mortality in patients with acute thoracic aortic lesions, and must therefore be considered the gold standard in these situations.
